LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 18

Search options

  1. Article ; Online: Role of preoperative zinc, magnesium and budesonide gargles in Postoperative Sore Throat (POST) - a randomised control trial.

    Bhanwra, Aakanksha / Palta, Sanjeev / Saroa, Richa / Saxena, Puja / Bhanwra, Sangeeta / Jain, Aditi

    BMC anesthesiology

    2024  Volume 24, Issue 1, Page(s) 164

    Abstract: Background: Post-operative sore throat (POST) has an incidence ranging from 21 to 80%. To prevent the development of POST, several pharmacological measures have been tried. Aim of this study was to compare the efficacy of preoperative zinc, magnesium ... ...

    Abstract Background: Post-operative sore throat (POST) has an incidence ranging from 21 to 80%. To prevent the development of POST, several pharmacological measures have been tried. Aim of this study was to compare the efficacy of preoperative zinc, magnesium and budesonide gargles in reducing the incidence and severity of POST in patients who underwent endotracheal intubation for elective surgeries.
    Methods: We conducted a prospective, randomized, double-blind, controlled equivalence trial in 180 patients admitted for elective surgical procedures under general anaesthesia. Patients were randomised into three groups; group Z received 40 mg Zinc, group M received 250 mg Magnesium Sulphate and group B received 200 µg Budesonide in the form of 30 ml tasteless and colourless gargle solutions. Sore throat assessment and haemodynamic recording was done postoperatively at immediate recovery (0 h) and 2, 4, 6, 8, 12 and 24 h post-operatively. POST was graded on a four-point scale (0-3).
    Results: POST score was comparable at all recorded time points i.e. 0,2,4,6,8,12 and 24 h. Maximum incidence was seen at 8 h in group B (33.3%) and the minimum incidence was at 24 h in group Z (10%) (p > 0.05). It was found that the incidence of POST was more in the surgeries lasting longer than 2 h in all groups. This difference was found to be statistically significant in Groups M and B. The incidence of POST was found to be comparable between laparoscopic and open procedures.
    Conclusion: Magnesium, zinc and budesonide have an equivocal effect in the prevention of POST at different time points. The incidence of sore throat increases significantly in surgeries lasting more than two hours if magnesium or budesonide have been used as premedicant. Duration of surgery is an independent predictor for POST.
    Trial registration: CTRI/2021/05/033741 Date-24/05/2021(Clinical Trial Registry of India).
    MeSH term(s) Humans ; Pharyngitis/prevention & control ; Pharyngitis/etiology ; Budesonide/administration & dosage ; Budesonide/therapeutic use ; Double-Blind Method ; Female ; Male ; Prospective Studies ; Adult ; Postoperative Complications/prevention & control ; Postoperative Complications/epidemiology ; Preoperative Care/methods ; Zinc/administration & dosage ; Middle Aged ; Magnesium Sulfate/administration & dosage ; Intubation, Intratracheal ; Magnesium/administration & dosage ; Incidence ; Elective Surgical Procedures ; Young Adult ; Anesthesia, General/methods
    Chemical Substances Budesonide (51333-22-3) ; Zinc (J41CSQ7QDS) ; Magnesium Sulfate (7487-88-9) ; Magnesium (I38ZP9992A)
    Language English
    Publishing date 2024-05-01
    Publishing country England
    Document type Journal Article ; Randomized Controlled Trial
    ZDB-ID 2091252-3
    ISSN 1471-2253 ; 1471-2253
    ISSN (online) 1471-2253
    ISSN 1471-2253
    DOI 10.1186/s12871-024-02534-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Case Based Learning in Teaching Pharmacology to Undergraduate Medical Students.

    Garg, Preeti / Bhanwra, Sangeeta

    Cureus

    2022  Volume 14, Issue 9, Page(s) e29187

    Abstract: Background With the new competency-based curriculum coming into effect we need to introduce newer teaching-learning methods to help students improve their learning and acquire necessary knowledge and skills. Hence to integrate pharmacology with clinical ... ...

    Abstract Background With the new competency-based curriculum coming into effect we need to introduce newer teaching-learning methods to help students improve their learning and acquire necessary knowledge and skills. Hence to integrate pharmacology with clinical sciences and involve the students in their learning process, case-based learning (CBL) has been found to be very successful. Therefore the present study was planned to introduce CBL as a new teaching-learning method in pharmacology and to know the perceptions of the students regarding this method.  Objectives The study aimed to introduce CBL to Bachelor of Medicine and Bachelor of Surgery (MBBS) students as a method of teaching pharmacology and the perceptions of the students regarding CBL were noted. Methodology After seeking institutional review board approval and sensitizing the students and faculty about this new teaching-learning method, CBL sessions were conducted on a few topics. Perceptions of the students were recorded on a feedback questionnaire and the results were analyzed. Results Ninety-five percent of students agreed that CBL helped in better comprehension of the concepts. Ninety-six percent of the students found CBL interesting and 96% of students said that CBL will help them correlate pharmacology clinically. Conclusions The students felt that CBL is an effective learning tool and would promote the clinical application of pharmacology.
    Language English
    Publishing date 2022-09-15
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2747273-5
    ISSN 2168-8184
    ISSN 2168-8184
    DOI 10.7759/cureus.29187
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: A study of non-prescription usage of antibiotics in the upper respiratory tract infections in the urban population.

    Bhanwra, Sangeeta

    Journal of pharmacology & pharmacotherapeutics

    2013  Volume 4, Issue 1, Page(s) 62–64

    Keywords covid19
    Language English
    Publishing date 2013-03-30
    Publishing country India
    Document type Journal Article
    ZDB-ID 2593227-5
    ISSN 0976-5018 ; 0976-500X
    ISSN (online) 0976-5018
    ISSN 0976-500X
    DOI 10.4103/0976-500X.107687
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: 'Phenytoin: Shepherd or Wolf in Disguise? Phenytoin-Induced Neurotoxicity: A Case Series.

    Arora, Manali / Boruah, Deb K / Thakker, Vishal / Bhanwra, Sangeeta

    Neurology India

    2021  Volume 69, Issue 4, Page(s) 1014–1017

    Abstract: Phenytoin is a commonly used antiepileptic drug for various types of seizure disorders except for absent seizures. Long-term dose-dependent neurological side effects of phenytoin therapy include cerebellar atrophy, cerebral atrophy, and brain stem ... ...

    Abstract Phenytoin is a commonly used antiepileptic drug for various types of seizure disorders except for absent seizures. Long-term dose-dependent neurological side effects of phenytoin therapy include cerebellar atrophy, cerebral atrophy, and brain stem atrophy. Skull hyperostosis, gum hypertrophy, and megaloblastic anemia are other known effects of long-term therapy. We present four cases depicting clinical and neuroimaging findings of phenytoin-induced toxicity.
    MeSH term(s) Anticonvulsants/adverse effects ; Epilepsy/drug therapy ; Humans ; Phenytoin/adverse effects ; Seizures/chemically induced ; Seizures/drug therapy
    Chemical Substances Anticonvulsants ; Phenytoin (6158TKW0C5)
    Language English
    Publishing date 2021-09-10
    Publishing country India
    Document type Case Reports
    ZDB-ID 415522-1
    ISSN 1998-4022 ; 0028-3886
    ISSN (online) 1998-4022
    ISSN 0028-3886
    DOI 10.4103/0028-3886.323888
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: A study of non-prescription usage of antibiotics in the upper respiratory tract infections in the urban population

    Sangeeta Bhanwra

    Journal of Pharmacology and Pharmacotherapeutics, Vol 4, Iss 1, Pp 62-

    2013  Volume 64

    Keywords Therapeutics. Pharmacology ; RM1-950 ; Medicine ; R
    Language English
    Publishing date 2013-01-01T00:00:00Z
    Publisher Medknow Publications, Media Pvt Ltd
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  6. Article ; Online: Empagliflozin

    Sangeeta Bhanwra / Kaza Ahluwalia

    International Journal of Basic & Clinical Pharmacology, Vol 5, Iss 2, Pp 539-

    the latest SGLT2 inhibitor on the block

    2016  Volume 542

    Abstract: Empagliflozin, the latest SGLT2 inhibitor is a selective, highly potent and competitive inhibitor of SGLT2 leading to the lowering of plasma glucose level by letting the sugar pass in the urine. It has a good safety and efficacy profile and is quite ... ...

    Abstract Empagliflozin, the latest SGLT2 inhibitor is a selective, highly potent and competitive inhibitor of SGLT2 leading to the lowering of plasma glucose level by letting the sugar pass in the urine. It has a good safety and efficacy profile and is quite convenient to use for the patient as well, except for some increase in the urinary and genital mycotic infections in the recipients. [Int J Basic Clin Pharmacol 2016; 5(2.000): 539-542]
    Keywords Empagliflozin ; Blood sugar ; SGLT 2 inhibitor ; Therapeutics. Pharmacology ; RM1-950 ; Medicine ; R
    Language English
    Publishing date 2016-04-01T00:00:00Z
    Publisher Medip Academy
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  7. Article ; Online: The association of oral contraceptive pills with increase in intraocular pressure

    Sangeeta Bhanwra / Kaza Ahluwalia

    Journal of Pharmacology and Pharmacotherapeutics, Vol 6, Iss 1, Pp 51-

    Time for pharmacovigilance to step in

    2015  Volume 52

    Keywords Therapeutics. Pharmacology ; RM1-950 ; Medicine ; R
    Language English
    Publishing date 2015-01-01T00:00:00Z
    Publisher Medknow Publications, Media Pvt Ltd
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  8. Article: Author reply.

    Bhanwra, Sangeeta / Ahluwalia, Kaza

    Journal of pharmacology & pharmacotherapeutics

    2012  Volume 5, Issue 2, Page(s) 169

    Language English
    Publishing date 2012-07-04
    Publishing country India
    Document type Journal Article
    ZDB-ID 2593227-5
    ISSN 0976-5018 ; 0976-500X
    ISSN (online) 0976-5018
    ISSN 0976-500X
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Author reply

    Sangeeta Bhanwra / Kaza Ahluwalia

    Journal of Pharmacology and Pharmacotherapeutics, Vol 5, Iss 2, Pp 169-

    2014  Volume 169

    Keywords Therapeutics. Pharmacology ; RM1-950 ; Medicine ; R
    Language English
    Publishing date 2014-01-01T00:00:00Z
    Publisher Medknow Publications, Media Pvt Ltd
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  10. Article ; Online: A novel approach in treatment of rheumatoid arthritis

    Sangeeta Bhanwra / Kaza Ahluwalia

    International Journal of Basic & Clinical Pharmacology, Vol 4, Iss 3, Pp 598-

    Janus kinase inhibitors

    2015  Volume 600

    Abstract: Janus kinase (JAK) inhibitors are a new class of drugs that inhibit JAK enzymes, which are the main signal transducers for the majority of cytokines, growth factors, and interferons. These drugs work from inside the cell and are unique in a way that ... ...

    Abstract Janus kinase (JAK) inhibitors are a new class of drugs that inhibit JAK enzymes, which are the main signal transducers for the majority of cytokines, growth factors, and interferons. These drugs work from inside the cell and are unique in a way that their action interrupts the signaling involved in the inflammation. They include drugs like ruxolitinib, tofacitinib, both of which have been US Food and Drug Administration (USFDA) approved, and many others which are currently under trials. Tofacitinib was approved by USFDA in November 2012 for oral use in patients suffering with moderate to severe rheumatoid arthritis and do not respond to methotrexate. [Int J Basic Clin Pharmacol 2015; 4(3.000): 598-600]
    Keywords Rheumatoid arthritis ; Janus kinase inhibitors ; Tofacitinib ; Therapeutics. Pharmacology ; RM1-950 ; Medicine ; R
    Language English
    Publishing date 2015-06-01T00:00:00Z
    Publisher Medip Academy
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top